Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health is expected to continue to see strong growth and increased revenues through the introduction of new products and partnerships. However, they face potential risks and challenges that could impact their financial stability and margins. The company's success will depend on their ability to maintain high engagement and usage of their healthcare platform, as well as carefully measuring the ROI of their AI spending. Overall, Hinge Health has a positive outlook with potential for sustained growth and expansion.

Bears say

Hinge Health is heavily dependent on its AI technology to deliver automated care for joint and muscle health, which may not always be effective and could lead to decreased member satisfaction and retention rates. Additionally, the addition of surgery to its HingeSelect network may bring in significant revenue, but also comes with potential liability risks and may not fully align with its focus on non-invasive solutions. The company's high operating expenses and reliance on its AI technology could also make it vulnerable to market fluctuations and competition in the digital healthcare space.

HNGE has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 17 analysts, HNGE has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $77.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $77.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.